9065B |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Blood |
9065SP |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Serum/Plasma |
9065TI |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Tissue |
9065U |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9165B |
Ephedrine Screen, Blood |
9193U |
Methylphenidate and Metabolite Screen, Urine |
9200SP |
Mepivacaine Screen, Serum/Plasma |
9253B |
Propofol Screen, Blood |
9253SP |
Propofol Screen, Serum/Plasma |
9306U |
Anabolic Steroids Screen, Urine |
9317B |
Lidocaine and Metabolite (MEGX) Screen, Blood |
9317SP |
Lidocaine and Metabolite (MEGX) Screen, Serum/Plasma |
9317U |
Lidocaine and Metabolite (MEGX) Screen, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9404B |
Nicotine and Metabolite Screen, Blood |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |
9419B |
Thiopental and Metabolite Screen, Blood |
9419SP |
Thiopental and Metabolite Screen, Serum/Plasma |
9522B |
Methamphetamine and Amphetamine Screen, Blood |
9522SP |
Methamphetamine and Amphetamine Screen, Serum/Plasma |
9522U |
Methamphetamine and Amphetamine Screen, Urine |